Response to inhibition of androgen action of human ovarian cancer cells in vitro

INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?

1971 • 1,104 citations

Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis<xref ref-type="fn" rid="FN2">2</xref>

1983 • 543 citations

The Hormonal Activity of the Postmenopausal Ovary

1976 • 381 citations

The etiology and prevention of ovarian cancer

1975 • 170 citations

The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.

1985 • 161 citations

Ovarian and adrenal steroid production in the postmenopausal woman.

1976 • 122 citations

Monoclonal Antibody Against Human Ovarian Tumor-Associated Antigens

1986 • 111 citations

Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy.

1988 • 93 citations

Epidemiology and etiology of ovarian cancer: a review.

1985 • 88 citations

Androgen receptor predominance in human ovarian carcinoma

1987 • 70 citations

Tamoxifen therapy in recurrent epithelial ovarian carcinoma

1987 • 69 citations

Androgen and Estrogen Secretion by Normal and Neoplastic Ovaries in Premenopausal Women

1986 • 50 citations

High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.

1986 • 49 citations

Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma.

1982 • 32 citations

Steroid receptors in human ovarian malignancy. A review of four years tissue collection

1986 • 28 citations

Termination of Early Pregnancy by the 3β-Hydroxysteroid Dehydrogenase Inhibitor Epostane

1988 • 26 citations

Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas.

1985 • 25 citations

Androstenedione production by malignant epithelial ovarian tumors

1986 • 24 citations

Termination of Early Pregnancy by the 3β-Hydroxysteroid Dehydrogenase Inhibitor Epostane

1989 • 8 citations